Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Marimed (MRMD) over the last 15 years, with Q3 2025 value amounting to $136.6 million.

  • Marimed's Total Liabilities rose 851.32% to $136.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $136.6 million, marking a year-over-year increase of 851.32%. This contributed to the annual value of $129.4 million for FY2024, which is 2073.8% up from last year.
  • As of Q3 2025, Marimed's Total Liabilities stood at $136.6 million, which was up 851.32% from $131.2 million recorded in Q2 2025.
  • In the past 5 years, Marimed's Total Liabilities registered a high of $136.6 million during Q3 2025, and its lowest value of $37.6 million during Q1 2021.
  • In the last 5 years, Marimed's Total Liabilities had a median value of $86.6 million in 2023 and averaged $86.8 million.
  • Per our database at Business Quant, Marimed's Total Liabilities plummeted by 3625.37% in 2021 and then surged by 8753.65% in 2023.
  • Marimed's Total Liabilities (Quarter) stood at $49.2 million in 2021, then increased by 16.24% to $57.2 million in 2022, then surged by 87.54% to $107.2 million in 2023, then rose by 20.74% to $129.4 million in 2024, then grew by 5.49% to $136.6 million in 2025.
  • Its Total Liabilities was $136.6 million in Q3 2025, compared to $131.2 million in Q2 2025 and $134.1 million in Q1 2025.